BRSYF News and Press, Brainsway Ltd Ord From 08/21/18

Neuronetics, Inc. ( STIM ) is now trading at 8.32x forward sales after delivering a decent quarterly release with 28.5% revenue growth. The valuation seems too high if we compare with other peers, thus it may be time to liquidate the position. In this piece, there is further due diligence on...

Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. Eisai and Merck's liver cancer partnership pays off Company: Eisai ( OTCPK:ESALY ) and M...

The FDA grants 510(k) clearance for BrainsWay Ltd.'s ( OTCPK:BRSYF ) deep transcranial magnetic stimulation ( Deep TMS ) system for the treatment of adults with obsessive compulsive disorder (OCD), the first such clearance for a non-invasive medical device for the condition. More news on...

Brainsway ( OTCPK:BRSYF ): Q1 Revenue of $3.6M (+71.4% Y/Y). More news on: Brainsway Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...

Brainsway ( OTCPK:BRSYF ): FY Revenue of $11.1M (-3.5% Y/Y) Press Release More news on: Brainsway Ltd., Earnings news and commentary, Healthcare stocks news, ,